BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 4th Quarter - Termination

FARRAGUT PARTNERS ON BEHALF OF GENENTECH

via WALTER CONSULTING

4th Quarter (Oct 1 - Dec 31) · 2016Posted Apr 10, 2017Filing document ↗LDA record ↗

Income$10Kfee reported

Client

Name: FARRAGUT PARTNERS ON BEHALF OF GENENTECH
Description: Government Affairs Firm
Location: District of Columbia · United States of America

Registrant

Firm: WALTER CONSULTING
Description: Federal health care advocacy
Location: McLean, Virginia, United States of America

Lobbying activities

1 issue

Health Issues
General health care issues
LobbyistsSARAH WALTER
Covered position (SARAH WALTER): Former Legislative Director, Sen. John Breaux
TargetedSENATE

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

FARRAGUT PARTNERS ON BEHALF OF GENENTECH — Receipts Report